Evidence map›Paper›PMID 25995784›Full record

ArticleThe Pan African medical journal2014

[Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo].

Tshingani Koy, Henri Mukumbi, Ghislain Lubangi Muteba Malandala, Philippe Donnen, Michèle Wilmet-Dramaix

Abstract readComparative Study
In one paragraph

Article in The Pan African medical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tshingani KoyCentre de Recherche en Épidémiologie, Biostatistiques et Recherche Clinique, École de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgique.
Henri MukumbiActions Communautaires Sida/ Avenir Meilleur pour les Orphelins au Congo (AMOCONGO), commune de Kasa Vubu, Kinshasa, RD Congo.
Ghislain Lubangi Muteba MalandalaUniversité de Liège, Faculté de Médecine, Liège, Belgique.
Philippe DonnenCentre de Recherche en Épidémiologie, Biostatistiques et Recherche Clinique, École de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgique.
Michèle Wilmet-DramaixCentre de Recherche en Épidémiologie, Biostatistiques et Recherche Clinique, École de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgique.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveDemocratic Republic of the CongoDisease ProgressionDrug CombinationsFemaleFollow-Up StudiesHIV-1HIV InfectionsHumansLamivudineLopinavirMaleMiddle AgedRitonavirAnti-HIV AgentsDrug CombinationsLamivudineLopinavirlopinavir-ritonavir drug combinationRitonavirZidovudineantiretroviralHAARThuman immunodeficiencyKinshasa

Identifiers

PMID25995784
PMCPMC4430161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.